Please assess the completion status of the following clinical trial:

Trial Title: Discontinuation Order of Vasopressors in Septic Shock

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients 20 years of age or older~* patients of receiving concomitant therapy with norepinephrine and vasopressin for teh management of septic shock~* patients began to reduce the vasopressor~Exclusion Criteria:~* patients who expired or had care withdrawn while receiving norepinephrine and vasopressin~* patients being transferred into the ICU from an outside facility or the operating room~* patients who are suspected to have vasopressin deficiency (eg. HPA axis dysfunction, empty sella)~* acute myocardial infarction or Congestive heart failure (NYHA functional classification III or IV)~* acute mesenteric ischemia~* patients who were received other vasopressor except for norepinephrine or vasopressin

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vasopressin (Type: ACTIVE_COMPARATOR): Vasopressin will be reduced first (0.01 U/hour)
- Norepinephrine (Type: ACTIVE_COMPARATOR): Norepinephrine: Norepinephrine will be reduced first (0.1 microgram/kg/hour)

Based on this trial design, predict the completion outcome and termination type (if applicable).